Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Microbiota Transplantation for Steroid-refractory GVHD
NCT07602751Phase 2Recruiting
- Start
- Sep 2026
- Primary completion
- Jun 2028
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Fecal Microbiota Transplantation Capsule in Acute Graft-Versus-Host Disease (aGvHD). Started Sep 2026; status: recruiting.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT07602751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07602751.